title: Formation of a stabilized cysteine sulfinic acid is critical for the mitochondrial function of the parkinsonism protein DJ-1.
abstract: The formation of cysteine-sulfinic acid has recently become appreciated as a modification that links protein function to cellular oxidative status. Human DJ-1, a protein associated with inherited parkinsonism, readily forms cysteine-sulfinic acid at a conserved cysteine residue (Cys106 in human DJ-1). Mutation of Cys106 causes the protein to lose its normal protective function in cell culture and model organisms. However, it is unknown whether the loss of DJ-1 protective function in these mutants is due to the absence of Cys106 oxidation or the absence of the cysteine residue itself. To address this question, we designed a series of substitutions at a proximal glutamic acid residue (Glu18) in human DJ-1 that alter the oxidative propensity of Cys106 through changes in hydrogen bonding. We show that two mutations, E18N and E18Q, allow Cys106 to be oxidized to Cys106-sulfinic acid under mild conditions. In contrast, the E18D mutation stabilizes a cysteine-sulfenic acid that is readily reduced to the thiol in solution and in vivo. We show that E18N and E18Q can both partially substitute for wild-type DJ-1 using mitochondrial fission and cell viability assays. In contrast, the oxidatively impaired E18D mutant behaves as an inactive C106A mutant and fails to protect cells. We therefore conclude that formation of Cys106-sulfinic acid is a key modification that regulates the protective function of DJ-1.
authors.affiliation: Cell Biology and Gene Expression Unit, Laboratory of Neurogenetics, NIA, National Institutes of Health, Bethesda, Maryland 20892-3707, USA.
authors.forename: Jeff
authors.initials: J
authors.lastname: Blackinton
authors.forename: Mahadevan
authors.initials: M
authors.lastname: Lakshminarasimhan
authors.forename: Kelly J
authors.initials: KJ
authors.lastname: Thomas
authors.forename: Rili
authors.initials: R
authors.lastname: Ahmad
authors.forename: Elisa
authors.initials: E
authors.lastname: Greggio
authors.forename: Ashraf S
authors.initials: AS
authors.lastname: Raza
authors.forename: Mark R
authors.initials: MR
authors.lastname: Cookson
authors.forename: Mark A
authors.initials: MA
authors.lastname: Wilson
mesh_terms: D019943:Amino Acid Substitution; D000818:Animals; D045744:Cell Line, Tumor; D003545:Cysteine / Q000235:genetics / Q000378:metabolism*; D030342:Genetic Diseases, Inborn / Q000235:genetics / Q000378:metabolism; D018698:Glutamic Acid / Q000235:genetics / Q000378:metabolism; D006801:Humans; D047908:Intracellular Signaling Peptides and Proteins / Q000235:genetics / Q000378:metabolism*; D051379:Mice; D024101:Mitochondrial Proteins / Q000235:genetics / Q000378:metabolism*; D009154:Mutation; D015513:Oncogene Proteins / Q000235:genetics / Q000378:metabolism*; D010084:Oxidation-Reduction; D010300:Parkinson Disease / Q000235:genetics / Q000378:metabolism; D000071617:Protein Deglycase DJ-1; D013441:Sulfinic Acids / Q000378:metabolism*
chemical_list: D047908:Intracellular Signaling Peptides and Proteins; D024101:Mitochondrial Proteins; D015513:Oncogene Proteins; D013441:Sulfinic Acids; D018698:Glutamic Acid; C105131:PARK7 protein, human; D000071617:Protein Deglycase DJ-1; D003545:Cysteine